Periodontal Therapeutics Market Size, Share, By Type (Gingivitis, Mild to Moderate Periodontitis, Moderate to Advanced Periodontitis) By Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region - Trends, Analysis and Forecast till 2034

Periodontal Therapeutics Market Size was valued at USD 927.13 Million in 2024 and is expected to reach USD 1794.95 Million by 2034, growing at a CAGR of 7.5%

Periodontal diseases involve an inflammatory attack on the tissues that support teeth, including the gums, periodontal ligament, and alveolar bone. If left untreated, they will progress, causing loss of teeth, but may also be linked to other health disorders, such as diabetes and heart diseases. Periodontal therapeutics involves the treatment and management of such diseases. The ultimate purpose of periodontal disease treatment is to control an infection caused by harmful bacteria in the mouth, prevent further damage to the gums, bone, and ligament, and promote healing to establish a healthy environment for your teeth. The therapy chosen must, therefore, be based on the severity of the case. In all, the treatments usually start with nonsurgical modalities, like professional cleaning and antibiotics, then proceed to surgical intervention only in advanced cases where there is evidence of severe bone loss.

Plaque control is the basis of periodontal therapy today. This is achieved through two to four elements, depending on the degree of advancement of the disease: thorough dental prophylaxis, periodontal surgery, homecare, and extraction. A thorough dental prophylaxis is the very cornerstone of periodontal therapy. It needs to be performed under general anesthesia, including an adequately inflated endotracheal tube. A proper physical examination usually allows dentists to diagnose periodontitis. A periodontal probe is an instrument that aids a dentist in determining whether there is any loss of gum attachment. If there is, this instrument also permits them to measure the size or degree of the lost gums.

Dentist may also use an intraoral camera to let you see the interior of your mouth. This visual will help to know whether teeth and gums are bad or good. Your dentist can use this opportunity to point out the areas that are not so good. If your dentist finds any indication of gum disease, he may take some digital X-rays. Such radiographs can capture digital images of a patient's mouth almost instantly. After that, he can make a faster and more accurate diagnosis. All periodontal therapies begin with a professional dental cleaning. It is, of course, just the word for the cleaning your dentist suggests you do for yourself when you visit them routinely for dental checkups. These procedures help clear the first layer of plaque and tartar, or hardened plaque, off the teeth. Specialized treatments for active periodontal disease follow this.

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

Key Drivers of Target Market:

Prevalence of the Disease

• Infections from the disease are becoming frequent among most of the global population. However, it has been estimated that nearly 1 billion adults across the world have periodontal disease. Several factors can account for this increasing prevalence.

Age of Populations

• The risk factor of periodontal disease is characterized by aging in the global population. With age, various problems of gums receding also come into play, and the immune functions tend to reduce, among other factors that increase this propensity for disease.

Unhealthy Lifestyles

• Certain lifestyle activities, such as smoking and poor eating habits, coupled with the practice of maintaining poor oral hygiene, expose one to a greater risk of acquiring periodontal disease. Smoking diminishes the immune system's ability to resist bacterial infection in the gums. A diet high in sugar and carbohydrates provides the necessary food for their multiplication in the mouth.

Increased Awareness of Oral Health

• Although some of the increased periodontal disease statistics can be attributed to better detection and diagnosis, this prevalence is actually increased. This could be partly due to the growing public awareness regarding oral health and maintaining good oral hygiene habits. After all, this very awareness also drives the periodontal therapeutics market by increasing the number of individuals who become more aggressive in seeking treatment for gum disease.

Restrains:

Expenses Prevalent

• The treatment of periodontal conditions is very costly, especially if it involves surgery. Regarding some patients' financial point of view, it may be financially unviable. For such patients, especially those with minimal or no dental insurance coverage, the treatment cost can be a worthy factor to consider. The presence or absence of insurance and the severity of the condition commonly affect the price of treatment, in addition to the expertise of the dental professional and its location. Bone grafting or complex flap surgeries come at a higher rate.

Shortfall of Dental Insurance Coverage

• Not everyone has dental insurance, and the coverage for periodontal treatment varies. This restricted financial access could constrain market growth. Dental insurance plans limit the coverage of periodontal procedures, placing more of the cost burden directly on the patient. There is an annual maximum in some plans, which can quickly be exhausted with periodontal treatment; therefore, the patient bears all additional costs.

 Opportunities:

Rising Demand for Periodontal Therapeutics:

• The market for periodontal therapeutics has inspiring growth opportunities. With a high prevalence of the disease, the patient pool admitted for treatment is large. Moreover, increasing public awareness related to oral hygiene improves the chances of more people coming to treat gum problems.
• Advances in minimally invasive surgery techniques, regenerative therapies, and new antibiotic development against periodontal pathogens can result in more productive and amicable treatment options, hence many more subjects seeking treatment. Solutions to affordable issues through an expansion in dental insurance or alternative financing options for periodontal procedures would open the market to more patients.

The market is segmented based on Type, Distribution Channels, and Region.

By Type:

• Gingivitis: The share would be pro for gingivitis since it is more prevalent than severe forms. Although just the first phase of the pathologic process, Gingivitis has its fair share of prevalence in a more significant proportion of the population. This translates to a larger market for gingivitis treatment products, which include medicated mouthwashes, special toothpaste, and professional cleanings.
• Mild to Moderate Periodontitis: This will be a large, definite sector. As gum disease evolves into gingivitis, these cases lean more toward this category. The market reflects this by showing growth in treatments, such as scaling and root planning, known as deep cleaning, localized antibiotics, and some surgical procedures in the more advanced cases of mild to moderate periodontitis.
• Moderate to Advanced Periodontitis: This is a smaller segment due to the lower population with this severity. This would be the most severe form of gum disease, with a smaller population than gingivitis or mild/moderate periodontitis. However, this segment would grow as more possibilities of treatment options, such as regenerative therapies or minimally invasive surgeries, come up. Given that these advancements continue to make treatment more effective and less costly, it could open further markets for moderate to advanced periodontitis.

By Distribution Channels:

• Hospital Pharmacies: Historically, hospital pharmacies have held the largest share of the periodontal therapeutics market. This is understandable, given the designation of advanced periodontal treatment being reduced to a hospital setup. Certain medications used in these procedures, often potent antibiotics, might require stricter control and oversight from a hospital environment.
• Retail Pharmacies: These are increasingly becoming important players. This is driven by the expanding availability of easily accessible over-the-counter and prescription medications for cases of gingivitis or generally mild periodontitis. Most of these drugs, mostly in the form of medicated mouthwashes or certain antibiotics, are easily dispensed at a local pharmacy, hence making access easier for patients having milder forms of gum diseases.
• Online Pharmacies: These are expected to have the highest growth in the periodontal therapeutics market, riding on the trend of online shopping and competitive pricing for a few products. Most of the medications that are easily taken can be more conveniently and, therefore, cost-effectively done through online pharmacies.

Regional Insights

• North America: This region retains the largest market share at this point. Factors attributed to this domination include High expenditure on healthcare in the region. Extensive coverage for dental insurance to make treatments more accessible. The aging population is more prone to periodontal disease. However, growth in this region could be slower than in other regions because many dental care infrastructures are already in place, and markets in some areas have been saturated.
• Asia Pacific: The periodontal therapeutics market in the Asia Pacific region is expected to grow at the fastest rate. Growth in this region will increase due to increased disposable income among people, enabling them to spend on their oral health. Awareness about oral hygiene and the need for periodontal treatment is on an upward surge. The region has a huge and aging population comparable to that of North America; however, the growth prospect might be higher compared to North America due to less saturation of periodontal treatments.
• Europe: This is another large market with a highly well-built healthcare infrastructure and good accessibility to dental care. Therefore, it is a mature market for the sector with only steady growth. Further growth in the European market would be driven mainly by better treatment options and increased public awareness about oral health.
• Latin America: with improved disposable incomes, people in Latin American countries can afford to take better care of their health, including dental care, which therefore raises the likelihood of their expenditure on periodontal treatments. Increasing awareness of oral health and the need to prevent periodontal disease creates demand for the treatment modality. Some governments in Latin American countries have initiated programs to facilitate access to dental treatment, possibly enlarging the potential of the periodontal therapeutics market. A growing middle class having more excellent financial resources results in a more significant consumer base for periodontal
• Middle East & Africa: Economic growth in most countries of MEA has enabled people to invest in healthcare, including oral health. Similar to Latin America, growing public awareness about oral health and the resulting potential demand for periodontal treatments can be witnessed; some governments in this region are introducing programs for access to better dental care, which could expand the market.

Periodontal Therapeutics Market Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study segmented the target market report based on Type, Distribution Channel and Region.

Segmentation:

By Type:

• Gingivitis
•  Mild to Moderate periodontitis
• Moderate to Advanced Periodontitis

By Distribution Channels:

• Hospital Pharmacies
•  Retail Pharmacies
•  Online Pharmacies

By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating the Periodontal Therapeutics Market include 3M Company, Dentsply Sirona, Medtronic, PFIZER INC, Biolase, Bausch Health Companies Inc., Dexcel Pharma, Planmeca, Kaken Pharmaceutical, Straumann AG.

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

• In December 2023, Ottawa launches $13B dental-care program with kids and seniors first up for coverage. That staggered application process is meant to make the rollout as smooth as possible. The government says it expects millions of people to avail themselves of this new component of Canada's social safety net.

• 3M Company

• Company Overview
• Product Portfolio
• Key Highlights
• Financial Performance
• Business Strategies

•  Dentsply Sirona
• Medtronic
• PFIZER INC
• Biolase
•  Bausch Health Companies Inc.
•  Dexcel Pharma
•  Planmeca
• Kaken Pharmaceutical
• Straumann AG

“*” marked represents similar segmentation in other categories in the respective section.

Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

Market Preview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Type
  • Market Snippet, By Distribution Channels
  • Market Snippet, By Region
• Opportunity Map Analysis

Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Market Trends
• Product Launch
• Merger and Acquisitions
• Impact Analysis
• PEST Analysis
• Porter’s Analysis

Market Segmentation, Type, Forecast Period up to 10 Years, (USD Mn)

• Overview
  • Market Value and Forecast (USD Mn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Gingivitis
  • Overview
  • Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Mild to Moderate Periodontitis
  • Overview
  • Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Moderate to Advanced Periodontitis
  • Overview
  • Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, Distribution Channels, Forecast Period up to 10 Years, (USD Mn)

• Overview
  • Market Value and Forecast (USD Mn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Retail Pharmacies
  • Overview
  • Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Online Pharmacies
  • Overview
  • Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By Region, Forecast Period up to 10 Years, (USD Mn)

• Overview
  • Market Value and Forecast (USD Mn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Regional Trends
• North America
  • Market Size and Forecast (USD Mn), By Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Mn), By Distribution Channels, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Mn), By Country, Forecast Period up to 10 Years
    • U.S
    • Canada
• Asia Pacific
  • Market Size and Forecast (USD Mn), By Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Mn), By Distribution Channels, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Mn), By Country, Forecast Period up to 10 Years
    • India
    • Japan
    • South Korea
    • China
    • Rest of Asia Pacific
• Europe
  • Market Size and Forecast (USD Mn), By Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Mn), By Distribution Channels, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Mn), By Country, Forecast Period up to 10 Years
    • UK
    • Germany
    • France
    • Russia
    • Italy
    • Rest of Europe
• Latin America
  • Market Size and Forecast (USD Mn), By Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Mn), By Distribution Channels, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Mn), By Country, Forecast Period up to 10 Years
    • Brazil
    • Mexico
    • Rest of Latin America
• Middle East and Africa
  • Market Size and Forecast (USD Mn), By Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Mn), By Distribution Channels, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Mn), By Country, Forecast Period up to 10 Years
    • GCC
    • Israel
    • South Africa
    • Rest of Middle East and Africa

Competitive Landscape

• Heat Map Analysis
• Company Profiles

• 3M Company
• Dentsply Sirona
• Medtronic
• PFIZER INC
• Biolase
•  Bausch Health Companies Inc.
•  Dexcel Pharma
•  Planmeca
• Kaken Pharmaceutical
• Straumann AG

The Last Word

• Future Impact
• About Us
• Contact